Follow
Martin Hemmerling
Martin Hemmerling
Medicinal Chemistry, RIA iMed, AstraZeneca
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
Linking increased airway hydration, ciliary beating, and mucociliary clearance through ENaC inhibition
ABM Aastrand, M Hemmerling, J Root, C Wingren, J Pesic, E Johansson, ...
American Journal of Physiology 308, L22-L32, 2015
782015
Selective nonsteroidal glucocorticoid receptor modulators for the inhaled treatment of pulmonary diseases
M Hemmerling, S Nilsson, K Edman, S Eirefelt, W Russell, R Hendrickx, ...
Journal of Medicinal Chemistry 60 (20), 8591-8605, 2017
542017
Chemical Compounds 572
M Berger, J Dahmén, K Edman, A Eriksson, B Gabos, T Hansson, ...
US Patent App. 13/429,177, 2012
512012
Investigation of the Lewis acid mediated stereoselective cyclization of cationic aminyl radicals leading to substituted pyrrolidines
Å Sjöholm, M Hemmerling, N Pradeille, P Somfai
Journal of the Chemical Society, Perkin Transactions 1, 891-899, 2001
292001
Probing the diastereoselectivity in the cyclization of cationic aminyl radicals
M Hemmerling, Å Sjöholm, P Somfai
Tetrahedron: Asymmetry 10 (21), 4091-4094, 1999
251999
Precise and systematic end group chemistry modifications on PAMAM and poly (l-lysine) dendrimers to improve cytosolic delivery of mRNA
F Joubert, MJ Munson, A Sabirsh, RM England, M Hemmerling, ...
Journal of Controlled Release 356, 580-594, 2023
212023
Acetogenic isoquinoline alkaloids. XXIII. Structure of the naphthyl isoquinoline alkaloid dioncophylline A
G Bringmann, R Zagst, B Schöner, H Busse, M Hemmerling, C Burschka
Acta Crystallographica Section C: Crystal Structure Communications 47 (8 …, 1991
211991
Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators
M Hemmerling, K Edman, M Lepistö, A Eriksson, S Ivanova, J Dahmén, ...
Bioorganic & Medicinal Chemistry Letters 26 (23), 5741-5748, 2016
202016
Potential strategies for increasing drug-​discovery productivity
JG Cumming, MRV Finlay, F Giordanetto, M Hemmerling, T Lister, ...
Future Medicinal Chemistry 6, 515-527, 2014
182014
Hydroxyalkyl compounds
T Eriksson, P Hansen, M Hemmerling, K Henriksson, T Klingstedt, ...
US Patent 6,943,188, 2005
162005
Phenyl and benzodioxinyl substituted indazoles derivatives
M Berger, H Rehwinkel, J Dahmén, A Eriksson, T Hansson, N Hossain, ...
US Patent 8,211,930, 2012
132012
Phenyl or Pyridinyl Substituted Indazoles Derivatives
M Berger, H Rehwinkel, J Dahmén, T Hansson, N Hossain, H Johanssson, ...
US Patent App. 12/468,494, 2010
122010
Chemical compounds 572
M Berger, J Dahmén, K Edman, A Eriksson, B Gabos, T Hansson, ...
US Patent 7,728,030, 2010
112010
Chemical compounds
M Berger, L Bergstrom, J Dahmen, A Eriksson, B Gabos, M Hemmerling, ...
US Patent App. 11/986,555, 2008
112008
Indazolyl sulphonamide derivatives useful as glucocorticoid modulators
M Berger, L Bergstrom, J Dahmen, A Eriksson, B Gabos, M Hemmerling, ...
US Patent 8,030,340, 2011
72011
Chemical Compounds 572
M Berger, J Dahmén, K Edman, A Eriksson, B Gabos, T Hansson, ...
US Patent App. 12/643,504, 2010
72010
Imidazo and thiazolopyridines as JAK3 kinase inhibitors
M Hemmerling, T Klingstedt
US Patent App. 10/556,228, 2006
72006
New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition
M Giorgetti, N Klymiuk, A Bähr, M Hemmerling, L Jinton, R Tarran, ...
European journal of pharmacology 904, 174123, 2021
62021
Discovery of AZD5423, a potent and selective non-steroidal glucocorticoid receptor modulator for the inhaled treatment of respiratory diseases
T Hansson, M Berger, J Dahmen, K Edman, A Eriksson, B Gabos, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013
52013
Chemical compounds 572
M Berger, J Dahmén, K Edman, A Eriksson, B Gabos, T Hansson, ...
US Patent 8,143,290, 2012
52012
The system can't perform the operation now. Try again later.
Articles 1–20